Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: PF-07242813
DRUG: Placebo

Sponsor

Pfizer